Mortality and morbidity patterns among HIV patients with prognostic markers in a tertiary care hospital in southern India by Rajeev A & Sharma A
 Australasian Medical Journal AMJ 2011, 4, 5, 273-276 
 
 
273 
 
                              RESEARCH 
  
Please cite this paper as: A Rajeev, Sharma A. Mortality and 
morbidity  patterns  among  HIV  patients  with  prognostic 
markers in a tertiary care hospital in Southern India. AMJ 
2011, 4, 5, 273-276 
http//dx.doi.org/10.4066/AMJ.2011.614 
 
 
 
 
 
 
  
 
 
 
 
 
Abstract 
 
Background 
Opportunistic  infections  are  an  important  cause  of 
morbidity  and  mortality  in  persons  infected  with  HIV.  In 
recent years, antiretroviral treatment (ART) and prophylaxis  
against  various  other  opportunistic  infections  have 
contributed  to  a  decrease  in  AIDS-related  mortality.  We 
conducted a study of HIV infected inpatients in our centre 
to  study  the  various  factors  contributing  to  mortality  in 
HIV/AIDS  patients  and  to  study  the  role  of  antiretroviral 
drugs in increasing longevity.  
 
Method   
We  retrospectively  reviewed  the  medical  records  of 
HIV/AIDS  patients  who  were  admitted  to  a  tertiary  care 
hospital from 1 January 2005 to 28 February 2006. Socio 
demographic  information,  CD4  lymphocyte  counts 
(wherever available); diagnoses at discharge, incidence  of 
opportunistic infections in patients and final outcome of the 
patients were collected.  
 
Results 
There was no difference in mean age between the patients  
 
who  died  and  those  who  are  surviving.  Body  weight  was 
comparatively  lower  for  the  patients  who  died  than  the 
survivors.  Albumin  levels  were  significantly  lower  among 
those who died (0.56 + 1.29 versus 2.73 + 1.13). CD4 counts 
did not predict a worse prognosis. History of fever (76.7% 
versus  53.17%)  and  weight  loss  (56.7%  versus  33.33%) 
predictably pointed to a bad prognosis.  
 
On  the  brighter  side,  administration  of  specific  therapy 
which  included  Lamivudine  was  associated  with  a  better 
outcome (OR - 0.07, p = 0.004) than any other combination 
of ART.  
 
Conclusion 
The above findings could be a rough guide for evaluating 
the status of HIV/AIDS patients who cannot afford frequent 
medical investigations in developing countries. Moreover as 
in our study, it was found that CD4 count was not a very 
reliable marker for the prognosis in such patients. A broader 
study could be a clue to a more cost-effective and cheaper 
alternative  mode  of  assessment  for  HIV/AIDS  patients  in 
developing countries  where  medical facilities are not just 
unaffordable but also scanty. 
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Background 
The HIV epidemic is currently in its fourth decade with no 
sign of abating.
1 Opportunistic infections are an important 
cause of morbidity and mortality in persons infected with 
HIV.
2 In recent years, ART and prophylaxis against various 
other  opportunistic  infections  have  contributed  to  a 
decrease in AIDS-related mortality.
3 The inpatient admission 
rate  has  fallen  in  our  centre  with  increasing  use  of  ART 
among  HIV  positive  individuals  (Table  1).  However,  the 
crude mortality of inpatients has not changed much possibly 
underlining the importance of the extraneous factors such 
as  opportunistic  infections  and  malignancies.
4  We 
conducted a study of HIV infected inpatients in our centre 
to  study  the  various  factors  contributing  to  mortality  in 
HIV/AIDS  patients  and  to  study  the  role  of  antiretroviral 
drugs in increasing longevity. 
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Table 1:  Admissions and deaths due to HIV and related 
causes in our institution during various years 
Year  1998  1999  2000  2001 
Admissions  68  120  150  195 
Deaths  8  7  15  23 
         
Year   2002  2003  2004  2005 
Admissions   378  400  247  209 
Deaths  35  36  26  28 
 
Method 
Ethics  committee  approval  was  obtained  from  the 
Institutional  Ethics  Committee,  Kasturba  Medical  College, 
Mangalore  (India)  before  embarking  on  the  study.  We 
retrospectively  reviewed  the  medical  records  of  HIV/AIDS 
patients  who  were  admitted  to  a  tertiary  care  teaching 
hospital in South India from 1 January 2005 to 28 February 
2006. This study duration was randomly selected to avoid 
any selection bias. The case files of all the patients admitted 
during this duration in the medical HIV unit were included in 
the study. We had to restrict the sample size to whatever 
cases available for the study duration.  Sociodemographic 
information, CD4 lymphocyte counts (wherever available); 
diagnoses at discharge, incidence of opportunistic infections 
in  patients  and  final  outcome  of  the  patients  were 
collected.
5 Case dairies of patients were collected (n = 157) 
until  30  fatal  events  were  available  so  that  meaningful 
statistical  analysis  could  be  conducted  between  the 
surviving and dead patients. It has to be commented here 
that CD4 counts were not available in the case diaries of 
several patients as the cost of the test was high during that 
time and many patients could not afford the same. 
 
The patients were classified for analysis purposes as those 
who were on ART or no ART and further those on ART with 
Lamivudine and those without. A databank was created in 
SPSS version 15.0 for windows. A descriptive analysis of the 
sample  was  done.  The  continuous  variables  were 
summarised  as  means  and  standard  deviations.  The 
differences between two groups were subjected to test of 
hypothesis using student’s T-test. Categorical variables were 
subjected to frequency tabulation and further chi-squared 
test was carried out to find statistical significance wherever 
necessary.  Odds  ratios  were  calculated  to  find  the 
association  between  various  factors  and  death  in  various 
groups. Univariate survival analysis using the Kaplan-Meier 
method was applied to find the differences in survival rates 
between those on ART and those specifically on Lamivudine 
containing ART. The value of p < 0.05 was defined as the 
limit for statistical significance. 
 
Results  
A total of 157 case files were included in the study. Out of 
these 40 were female and 117 were males. There were 30 
deaths recorded out of the cases during the study duration. 
Average  age  of  the  subjects  was  36.28  years  and  their 
average weight was 49.47 kg.  
 
There was no difference in mean age between the patients 
who died (35.13 + 8.5 years) and those who are surviving 
(36.56  +  10.2  years).  There  were  more  females  (28.57%) 
among  survivors  than  the  deceased  (13.3%)  though  this 
finding  was  not  statistically  significant.  Body  weight  was 
comparatively lower for the patients who died (44.89 kg + 
11.09) than the survivors (50.56 kg + 8.34) in spite of more 
females being part of the survivors. Serum albumin levels 
were significantly lower among those who died (0.56 + 1.29 
versus 2.73 + 1.13) (Table 2) 
Table  2:  Characteristics  of  the  subjects  enrolled  in  the 
study 
  Died 
(N=30) 
SD  Alive 
(N=127) 
SD  P 
Age  35.1  8.50  36.55  10.20  .48 
Weight  44.8  11.0  50.56  8.34  .06 
CD4  79.5  61.4  138.64  219.3  .29 
Albumin  .556  1.28  2.72  1.12  .00 
Hb%  10.0  3.40  10.29  1.98  .64 
 
Based on the Student’s T Test, haemoglobin (p = 0.29) and 
CD4 counts (wherever available, p = 0.64) could not predict 
a  worse  prognosis.  However  it  is  added  that  CD4  counts 
were available  for a very limited number of patients and 
hence analysis associated with them may not be significant. 
History  of  fever  (76.7%  versus  53.17%)  and  weight  loss 
(56.7%  versus  33.33%)  predictably  pointed  to  a  bad 
prognosis  in  terms  of  mortality  (based  on  the  chi  square 
test). Dyspnoea (36.7%) and dysphagia (23.3%) were more 
common  among  those  who  died.  Symptoms  such  as 
headache (36.7% versus 4.28%) and altered sensorium (16.7 
versus  6.1%)  indicated  a  worse  prognosis  in  terms  of 
mortality. Presence of candidiasis (60.0% versus 6.7%) and 
PCP  pneumonia  (20%  versus  5.56%)  called  for  more 
vigilance as the patients had a relatively bad prognosis if 
these  diseases  were  present.  On  the  brighter  side, 
administration  of  specific  therapy  which  included 
Lamivudine  (Fig.1)  was  associated  with  a  better  outcome 
(Odds  Ratio  (OR)  -  0.07,  p  =  0.004)  than  any  other 
combination of ART. As predicted by history, treatment with 
Amphotericin (OR 6.3, p = 0.03) and corticosteroids (OR - 4, 
p = 0.006) pointed towards a bad outcome. (Table 3)  
Survival of patients on Lamivudine
compared to those not on Lamivudine
Duration of survival in months
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Figure  1:  Survival  curve  of  patients  on  Lamivudine 
compared to those not on Lamivudine.  Australasian Medical Journal AMJ 2011, 4, 5, 273-276 
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The number of patients who died was 30. Causes of death 
among our patients were AIDS associated infections (n=8), 
other bacterial infections (n=2), other causes like respiratory 
failure,  encephalopathy  etc.  (n=5)  (Figure  2).  Cancers, 
cardiovascular  causes,  liver  failure  and  an  instance  of 
suicide were other indirect causes. Tuberculosis alone was 
not a predictor for death as such, although, there were a 
good  number  of  patients  (N=5)  who  died  of  tuberculosis 
complications. Another equally significant finding obtained 
was the duration of the disease. Eight among 30 deceased 
were diagnosed less than six months ago.  
 
Table 3. Clinical characteristics of the subjects enrolled in 
the study 
  Died 
(N=30) 
%  Alive 
(N=127) 
%  Odds 
Ratio 
P 
Females  4  13.3  36  28.57  0.39  0.14 
             
Anaemia  17  56.7  34  26.98  1.18  0.89 
Fever  23  76.7  67  53.17  2.82  0.03 
Weight loss  17  56.7  42  33.33  2.62  0.03 
Dysphagia  7  23.3  12  9.52  2.89  0.07 
Dyspnoea  11  36.7  23  18.25  2.59  0.05 
Headache  11  36.7  15  11.90  4.28  0.002 
Altered 
sensorium 
5  16.7  4  3.17  6.1  0.0015 
             
Candidiasis  18  60.0  23  18.25  6.71  <0.0001 
PCP  6  20.0  7  5.56  4.25  0.03 
             
ART  11  36.7  61  48.41  0.062  0.34 
Lamivudine  1  3.3  39  30.95  0.07  0.004 
Amphotericin  4  13.3  3  2.38  6.3  0.03 
Corticosteroids  10  33.3  14  11.11  4  0.006 
 
Eight pregnant women also were part of the study. Five of 
them were on Zidovudine prophylaxis and one was given 
Nevirapine. 
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Figure 2: Survival curve of patients on ART versus patients 
not on ART 
 
Discussion 
As  there  was  no  difference  in  mean  age  between  the 
patients who died and those who are surviving, we tend to 
conclude  that  age  probably  does  not  have  a  very  strong 
correlation as far as severity of the disease is concerned. 
But since the sample size is small and this was a very short 
study, we cannot categorically comment upon the same. 
A higher number of females among survivors indicates that 
women are relatively healthier and respond better to the 
antiviral drugs. In our study population it was found that, 
generally, women had less risk factors and the majority of 
the women got infected from their HIV-positive husbands. 
Due  to  the  same  reason  these  women  presented  to  the 
hospital earlier along with their spouses when the partners 
developed full blown AIDS (or presented with symptoms), 
and hence the women were checked for HIV and detected 
at an earlier stage. Lower body weight of the patients who 
died  compared  to  the  survivors  was  probably  due  to 
cachexia of the disease. Lower serum albumin levels in the 
deceased also point towards cachexia and decreased liver 
function. It was interesting to note that haemoglobin and 
CD4 counts could not predict a worse prognosis and were 
similar  in  both  the  survivors  and  the  deceased.  However 
since CD4 counts were available for a very limited number 
of patients owing to the high cost of the investigation, no 
statistical tests could be done based on the same. Fever and 
weight loss predicted a bad prognosis both due to cachexia 
as  well  as  opportunistic  infections.  Higher  occurrence  of 
dyspnoea and dysphagia among those who died is indicative 
of a fungal infection of the lungs and oesophagus. Headache 
and  altered  sensorium  indicated  a  worse  prognosis,  if 
present  in  the  patient  during  hospitalisation,  probably 
pointing towards meningitis which had a bad outcome.  
 
ARTs  containing  Lamivudine  were  associated  with  a 
significantly better outcome than any other combination of 
ART indicating that perhaps the HIV strains present in this 
region are more susceptible to this drug (Univariate survival 
analysis  using  the  Kaplan-Meier  method  to  find  the 
differences  in  survival  rates  between  those  on  ART  and 
those specifically on Lamivudine containing ART, Figure 1). 
Various antiretroviral regimens were in use during that time 
and  all  of  them  were  pre  Highly  Active  Anti  Retro  Viral 
Therapy (HAART). The purpose of this analysis was to see if 
any particular medication had significant benefit so that we 
could propose an affordable HAART (Highly Economical ART 
or HEART) treatment with Amphotericin and corticosteroids 
pointed  towards  a  bad  outcome  not  due  to  the  adverse 
effects of the drugs but due to the conditions they were 
used to be treated for, like fungal infections etc.  
 
Eight  among  30  deceased  were  diagnosed  less  than  six 
months  ago.  It  is  probably  they  had  approached  their 
physician  at  such  a  late  stage  that  ART  could  not  be 
initiated. 
 
Conclusion 
An early diagnosis and timely intervention with ART will give 
the patient a chance to live longer.  Further improvements 
in  availability  and  access  to  efficacious  and  cost-effective 
therapy of the disease are necessary to improve the patient 
outcomes.
6 In addition, prevention strategies, in particular 
chemoprophylaxis need to be further evaluated while the 
outcome of initiatives to make ART more widely available is 
being awaited.  Australasian Medical Journal AMJ 2011, 4, 5, 273-276 
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